$PRTA
PROTHENA CORP PUBLIC LTD CO

2015 Q2 Form 10-Q Financial Statement

#000155905315000034 Filed on August 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $278.0K $15.12M
YoY Change -98.16% 8954.49%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.520M $4.940M
YoY Change 11.74% 53.89%
% of Gross Profit
Research & Development $12.79M $8.615M
YoY Change 48.47% 5.74%
% of Gross Profit
Depreciation & Amortization $200.0K $200.0K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $18.31M $13.55M
YoY Change 35.13% 19.31%
Operating Profit -$18.04M $1.569M
YoY Change -1249.46% -114.02%
Interest Expense $40.00K $20.00K
YoY Change 100.0% 100.0%
% of Operating Profit 1.27%
Other Income/Expense, Net -$47.00K $17.00K
YoY Change -376.47% 21.43%
Pretax Income -$18.08M $1.586M
YoY Change -1240.1% -114.19%
Income Tax $195.0K $296.0K
% Of Pretax Income 18.66%
Net Earnings -$18.28M $1.290M
YoY Change -1516.82% -111.41%
Net Earnings / Revenue -6574.46% 8.53%
Basic Earnings Per Share -$0.59 $0.06
Diluted Earnings Per Share -$0.59 $0.06
COMMON SHARES
Basic Shares Outstanding 30.79M shares 21.96M shares
Diluted Shares Outstanding 30.79M shares 22.90M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $402.4M $303.9M
YoY Change 32.41% 170.13%
Cash & Equivalents $402.4M $303.9M
Short-Term Investments
Other Short-Term Assets $2.900M $1.600M
YoY Change 81.25% 45.45%
Inventory
Prepaid Expenses
Receivables $961.0K $1.491M
Other Receivables $0.00 $0.00
Total Short-Term Assets $406.2M $307.0M
YoY Change 32.3% 170.28%
LONG-TERM ASSETS
Property, Plant & Equipment $2.816M $3.340M
YoY Change -15.69% -10.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.100M $28.00K
YoY Change 7400.0% -95.33%
Total Long-Term Assets $4.964M $4.666M
YoY Change 6.39% 7.61%
TOTAL ASSETS
Total Short-Term Assets $406.2M $307.0M
Total Long-Term Assets $4.964M $4.666M
Total Assets $411.2M $311.7M
YoY Change 31.92% 164.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.865M $1.483M
YoY Change 93.19% 90.37%
Accrued Expenses $9.100M $7.800M
YoY Change 16.67% 13.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.46M $11.31M
YoY Change 18.96% 24.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $126.0K $2.000M
YoY Change -93.7% 42.86%
Total Long-Term Liabilities $2.488M $1.955M
YoY Change 27.26% 39.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.46M $11.31M
Total Long-Term Liabilities $2.488M $1.955M
Total Liabilities $15.94M $13.27M
YoY Change 20.19% 23.97%
SHAREHOLDERS EQUITY
Retained Earnings -$81.97M -$22.20M
YoY Change 269.25% 7.77%
Common Stock $314.0K $267.0K
YoY Change 17.6% 50.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $395.2M $298.4M
YoY Change
Total Liabilities & Shareholders Equity $411.2M $311.7M
YoY Change 31.92% 164.3%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$18.28M $1.290M
YoY Change -1516.82% -111.41%
Depreciation, Depletion And Amortization $200.0K $200.0K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$11.14M $6.220M
YoY Change -279.1% -190.67%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$320.0K
YoY Change -87.5% 39.13%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$40.00K -$320.0K
YoY Change -87.5% 60.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 133.7M 102.9M
YoY Change 29.93%
NET CHANGE
Cash From Operating Activities -11.14M 6.220M
Cash From Investing Activities -40.00K -320.0K
Cash From Financing Activities 133.7M 102.9M
Net Change In Cash 122.5M 108.8M
YoY Change 12.61% -1641.22%
FREE CASH FLOW
Cash From Operating Activities -$11.14M $6.220M
Capital Expenditures -$40.00K -$320.0K
Free Cash Flow -$11.10M $6.540M
YoY Change -269.72% -198.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 USD
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001559053
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31379986 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Prothena Corp plc
dei Trading Symbol
TradingSymbol
PRTA
prta Accrued Offering Costs
AccruedOfferingCosts
280000 USD
prta Accrued Offering Costs
AccruedOfferingCosts
41000 USD
CY2014Q4 prta Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
2285000 USD
CY2015Q2 prta Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
6399000 USD
CY2014Q2 prta Collaboration Revenue
CollaborationRevenue
14984000 USD
prta Collaboration Revenue
CollaborationRevenue
47080000 USD
CY2015Q2 prta Collaboration Revenue
CollaborationRevenue
278000 USD
prta Collaboration Revenue
CollaborationRevenue
871000 USD
CY2014Q4 prta Deferred Shares Par Value
DeferredSharesParValue
22
CY2015Q2 prta Deferred Shares Par Value
DeferredSharesParValue
22
CY2014Q4 prta Deferred Shares Share Issued
DeferredSharesShareIssued
0 shares
CY2015Q2 prta Deferred Shares Share Issued
DeferredSharesShareIssued
0 shares
CY2014Q4 prta Deferred Shares Share Outstanding
DeferredSharesShareOutstanding
0 shares
CY2015Q2 prta Deferred Shares Share Outstanding
DeferredSharesShareOutstanding
0 shares
CY2014Q4 prta Deferred Shares Shares Authorized
DeferredSharesSharesAuthorized
10000 shares
CY2015Q2 prta Deferred Shares Shares Authorized
DeferredSharesSharesAuthorized
10000 shares
CY2014Q4 prta Deferred Shares Value
DeferredSharesValue
0 USD
CY2015Q2 prta Deferred Shares Value
DeferredSharesValue
0 USD
prta Gain Losson Sublease
GainLossonSublease
-400000 USD
prta Gain Losson Sublease Noncash Portion
GainLossonSubleaseNoncashPortion
0 USD
prta Gain Losson Sublease Noncash Portion
GainLossonSubleaseNoncashPortion
-261000 USD
prta Numberof Votes
NumberofVotes
1 vote
CY2015Q1 prta Sublease Leases Optional Extension Term
SubleaseLeasesOptionalExtensionTerm
P1Y
CY2015Q1 prta Sublease Leases Term
SubleaseLeasesTerm
P3Y
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4722000 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2865000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1729000 USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
961000 USD
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
57000 USD
CY2015Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2014Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
98000 USD
CY2015Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
98000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1169000 USD
CY2015Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
469000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4711000 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5099000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
338106000 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
476876000 USD
CY2014Q4 us-gaap Assets
Assets
304116000 USD
CY2015Q2 us-gaap Assets
Assets
411164000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
299275000 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
406200000 USD
CY2014Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
4841000 USD
CY2015Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
4964000 USD
CY2014Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
137000 USD
CY2015Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
138000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
176677000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
303851000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
293579000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
402389000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
127174000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
108810000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27388005 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31379986 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27388005 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31379986 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
274000 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
314000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-483000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-426000 USD
CY2014Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
172000 USD
CY2015Q2 us-gaap Deferred Rent Credit
DeferredRentCredit
254000 USD
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2090000 USD
CY2015Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2264000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
167000 USD
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
165000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1720000 USD
CY2015Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2148000 USD
CY2014Q2 us-gaap Depreciation
Depreciation
200000 USD
us-gaap Depreciation
Depreciation
400000 USD
CY2015Q2 us-gaap Depreciation
Depreciation
200000 USD
us-gaap Depreciation
Depreciation
400000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
357000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
388000 USD
CY2014Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
30000 USD
CY2015Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3138000 USD
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2748000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
252000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
989000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
252000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
989000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4937000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9810000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5522000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10571000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1586000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19589000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18082000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-33018000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
296000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
447000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
461000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
436000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
442000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4177000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1908000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1491000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-768000 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-12000 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-30000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
138000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1560000 USD
CY2014Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
16000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
35000 USD
CY2015Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
40000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
66000 USD
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2214000 USD
CY2015Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2220000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
14227000 USD
CY2015Q2 us-gaap Liabilities
Liabilities
15944000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
304116000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
411164000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12039000 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13456000 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2188000 USD
CY2015Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2488000 USD
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5481000 USD
CY2015Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5557000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103422000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
134738000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-353000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68000 USD
us-gaap Net Income Loss
NetIncomeLoss
-33479000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
15000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24105000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25860000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
1290000 USD
us-gaap Net Income Loss
NetIncomeLoss
19142000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-18277000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-47000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
46000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
13552000 USD
us-gaap Operating Expenses
OperatingExpenses
27767000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
18313000 USD
us-gaap Operating Expenses
OperatingExpenses
33935000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1569000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
19588000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18035000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-33064000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4975000 USD
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4192000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
126000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-87000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000 USD
CY2014Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
496000 USD
CY2015Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
721000 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
353000 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
68000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3770000 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2685000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
102780000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
131481000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
390000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2268000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7832000 USD
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7915000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3121000 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2816000 USD
CY2015Q2 us-gaap Purchase Obligation
PurchaseObligation
2600000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8615000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17957000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12791000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23364000 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81970000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48491000 USD
CY2014Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
137000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
275000 USD
CY2015Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 USD
CY2014Q2 us-gaap Revenues
Revenues
15121000 USD
us-gaap Revenues
Revenues
47355000 USD
CY2015Q2 us-gaap Revenues
Revenues
278000 USD
us-gaap Revenues
Revenues
871000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1438000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2781000 USD
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2416000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4119000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
289889000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
395220000 USD
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
939000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1005000 shares
CY2015Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22898000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22927000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30792000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29106000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21959000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21922000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30792000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29106000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates, including critical accounting policies or estimates related to revenue recognition, share-based compensation and research and development expenses. The Company bases its estimates on historical experience and on various other market specific and other relevant assumptions that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Because of the uncertainties inherent in such estimates, actual results may differ materially from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0001559053-15-000034-index-headers.html Edgar Link pending
0001559053-15-000034-index.html Edgar Link pending
0001559053-15-000034.txt Edgar Link pending
0001559053-15-000034-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
prta-20150630.xml Edgar Link completed
prta-20150630.xsd Edgar Link pending
prta-20150630_cal.xml Edgar Link unprocessable
prta-20150630_def.xml Edgar Link unprocessable
prta-20150630_lab.xml Edgar Link unprocessable
prta-20150630_pre.xml Edgar Link unprocessable
prta2015q210-q.htm Edgar Link pending
prta2015q210-qxex311.htm Edgar Link pending
prta2015q210-qxex312.htm Edgar Link pending
prta2015q210-qxex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending